Peregrine Pharmaceuticals shares owned by Cannell Capital
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Cannell Capital
from 13F filings
Historical chart of Cannell Capital investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Cannell Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Cannell Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.1M | 86k | 12.35 |